• 
• 
• 
• 
• 
• 

Research and Clinical Interests

Dr. Shukla is a clinically oriented oncologic pathologist with special interest and expertise in diagnosis of Gynecologic and Breast tumors. She participates in multidisciplinary treatment planning meetings for breast and gynecologic cancer patients. Her research is focussed on a pursuit of morphological parameters and immunohistochemical markers for diagnosis of premalignant endocervical glandular lesions.

Selected Publications

Liang J, Mittal KR, Wei JJ, Yee H, Chiriboga L, Shukla P. Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. International journal of gynecological pathology. 2007;26:71.

Wen YH, Yee H, Goswami S, Shukla P. Expression of fascin-1 in serous tumors of ovary and correlation with tumor progression [Abstract]. Modern pathology. 2006;19:105.

Liang J; Mittal K, Wei J, Yee H, Goswami S, Chiriboga L, Shukla P. Utility of p16(INK4A), CEA, Ki67, p53 and ER/PR in the differential diagnosis of benign, premalignant and malignant glandular lesions of the uterine cervix [Abstract]. Laboratory investigation. 2005;85:92A.

Organizational Associations

International Society of Gynecological Pathologists; United States and Canadian Academy of Pathology; College of American Pathologists.

Selected Awards

CAP Training in Technology Award

Hospital Affiliations

Tisch Hospital
Bellevue Hospital